Price action
Daily adjusted bars
Snapshot
Key stats
- Market cap
- $180.8M
- P/E ratio
- --
- Forward P/E
- --
- Beta
- --
- 52W range
- $6.13 - $30.40
- Dividend yield
- --
- Volume
- 914.4K
- Sector
- CONSUMER CYCLICAL
Analyst
Consensus price target
Current
$6.46
Target
$18.57
AlphaYou verdict
Insider Cluster
C-suite + 2 other insiders bought $369K of BRCB this 14d.
- Smart money15.0/40
- Fundamentals0.8/35
- Technicals2.0/15
- Macro3.1/10
Receipts
Recent signals for this ticker
- LONGMay 23Insider Cluster
C-suite + 2 other insiders bought $369K of BRCB this 14d.
Public Recommendation·Checkpoints pending - LONGMay 20Insider Buy
Insider bought $73.0M of BRCB this 14d.
Public Recommendation·Checkpoints pending
Smart money
Insider, fund, and political flow
insider buy
Chief Operating Officer Geyer Clay Howard bought $300K
insider buy
Principal Accounting Officer Schmidt Michael Ryan bought $50K
insider buy
Chief Marketing Officer Wegener-Beyer Jessica Michele bought $20K
filing 13f fund flow
Renaissance Technologies LLC holds $1.7M (13F 2025-12-31)
filing 13f fund flow
Citadel Advisors LLC holds $9.0M (13F 2025-09-30)
filing 13f fund flow
Two Sigma Investments LP holds $380K (13F 2025-12-31)
Top trader activity
PendingCopy-trading signal layer from real US-equity operators. Wires in once the CopyTrading feed is mapped to US-stock tickers.
BTC Astro risk regime
PendingCross-asset risk timing overlay. Used as context only, never a primary stock source.
Reputation
Sources and actors behind this ticker
Source families
- SEC EDGAR Form 4
Source family
D7
92
+2.22%
66.3% hit
D15
28
+1.41%
60.7% hit
D30
pending
Actors and filers
- Cynosure Group, LLC
INSIDER
D7
1
+25.65%
100.0% hit
D15
pending
D30
pending
Checkpoint ledger
Public recommendation outcomes
No public recommendation checkpoints have landed for this ticker yet.
D7 appears first, then D15 and D30 as the call matures.
Each row is a public recommendation. Alpha columns compare the frozen issued price with SPY, QQQ, and sector ETF checkpoints when available.
Raw source coverage
Primary-source receipt chain
Fundamentals
Valuation, quality, growth
Valuation
- P/E--
- Forward P/E--
- P/S0.86
- P/B3.82
Quality
- Profit margin0.1%
- Operating margin5.0%
- ROE-30.5%
- ROA0.2%
Growth
- Revenue YoY--
- Earnings YoY--
- Beta--
- Dividend yield--
Technicals
Trend, momentum, levels
Trailing returns
- 5d+0.62%
- 20d+0.16%
- 60d+2.05%
Trend vs SMAs
- vs SMA50+0.49%
- vs SMA200-1.36%
52w range position
Computed from AV daily adjusted bars. No options-flow, IV, or order-book signals on this page yet.
Macro
Sector + regime context
- +16.8
macro regime shift
VIX 16.8 (mild) as of 2026-05-21
- +0.4
macro regime shift
10y-2y spread 43bps (flattish) as of 2026-05-22
- +102.5
macro regime shift
Industrial Production 102.5 (mild expansion) as of 2026-04-01
- +1.0
macro regime shift
Initial claims 209,000 vs 26w mean (ratio 0.98, neutral)
- +4.0
macro regime shift
CPI YoY 3.95% (hot vs Fed target)
Earnings
EPS beat / miss history
Debate
Key issues
Bullish view
- Chief Operating Officer Geyer Clay Howard bought $300K
- Principal Accounting Officer Schmidt Michael Ryan bought $50K
- Chief Marketing Officer Wegener-Beyer Jessica Michele bought $20K
- Renaissance Technologies LLC holds $1.7M (13F 2025-12-31)
Bearish view
No receipts on this side yet.
Arguments are pulled from contributing receipts (Form 4 / 13F / fundamentals / macro) for this ticker. Each side carries the count of receipts behind it, not an analyst headline count.
Track record
Recommendation receipts
vs SPY
S&P 500
Median alpha
+25.65%
Mean alpha
+25.65%
Hit rate
100.0%
Mean return
+27.25%
vs QQQ
Nasdaq-100
Median alpha
+24.29%
Mean alpha
+24.29%
Hit rate
100.0%
Mean return
+27.25%
D7 recommendation-counted alpha. Each receipt aggregates same-day same-direction signals into one row to avoid double-counting.